| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.663 | 0.007 | 0.663 | Immunomodulator | 0.244 0.12 DBMET02094 0.243 0.12 DBMET02095 0.249 0.116 DBMET02096 0.407 0.042 DBMET02097 0.267 0.102 DBMET02098 0.307 0.079 DBMET02099 | ||
| 0.581 | 0.008 | 0.581 | Antimitotic | 0.579 0.008 DBMET02094 0.51 0.011 DBMET02095 0.358 0.03 DBMET02096 0.361 0.03 DBMET02097 0.439 0.018 DBMET02098 0.432 0.019 DBMET02099 | ||
| 0.551 | 0.014 | 0.754 | Tyrosine kinase inhibitor | 0.754 0.005 DBMET02094 0.63 0.009 DBMET02095 0.14 0.095 DBMET02097 0.447 0.023 DBMET02098 0.679 0.007 DBMET02099 | DBMET02094 | |
| 0.562 | 0.057 | 0.562 | Apoptosis agonist | 0.268 0.196 DBMET02094 0.317 0.16 DBMET02095 0.466 0.085 DBMET02096 0.481 0.08 DBMET02097 0.25 0.215 DBMET02099 | ||
| 0.395 | 0.004 | 0.666 | Syk tyrosine kinase inhibitor | 0.666 0.002 DBMET02094 0.564 0.003 DBMET02095 0.096 0.03 DBMET02097 0.262 0.005 DBMET02098 0.665 0.002 DBMET02099 | DBMET02094 | |
| 0.379 | 0.015 | 0.537 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.537 0.004 DBMET02094 0.5 0.005 DBMET02095 0.237 0.048 DBMET02096 0.309 0.027 DBMET02097 0.423 0.01 DBMET02098 0.491 0.005 DBMET02099 | DBMET02094 | |
| 0.329 | 0.021 | 0.494 | Src kinase inhibitor | 0.494 0.006 DBMET02094 0.415 0.011 DBMET02095 0.12 0.108 DBMET02096 0.145 0.086 DBMET02097 0.27 0.031 DBMET02098 0.436 0.009 DBMET02099 | DBMET02094 | |
| 0.371 | 0.063 | 0.417 | Angiogenesis inhibitor | 0.379 0.06 DBMET02094 0.35 0.071 DBMET02095 0.237 0.133 DBMET02096 0.377 0.06 DBMET02097 0.417 0.048 DBMET02098 0.34 0.075 DBMET02099 | DBMET02098 | |
| 0.294 | 0.005 | 0.35 | Aurora-C kinase inhibitor | 0.343 0.004 DBMET02094 0.332 0.004 DBMET02095 0.256 0.009 DBMET02096 0.257 0.009 DBMET02097 0.314 0.004 DBMET02098 0.35 0.004 DBMET02099 | DBMET02099 | |
| 0.308 | 0.024 | 0.804 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.804 0.003 DBMET02094 0.711 0.003 DBMET02095 0.266 0.033 DBMET02096 0.427 0.006 DBMET02097 0.626 0.004 DBMET02098 0.796 0.003 DBMET02099 | DBMET02094 | |
| 0.414 | 0.131 | 0.857 | Antiinflammatory | 0.615 0.049 DBMET02094 0.649 0.041 DBMET02095 0.857 0.009 DBMET02096 0.792 0.016 DBMET02097 0.65 0.041 DBMET02098 0.68 0.035 DBMET02099 | DBMET02096 | |
| 0.288 | 0.014 | 0.384 | Polo-like kinase-3 inhibitor | 0.384 0.004 DBMET02094 0.356 0.005 DBMET02095 0.155 0.079 DBMET02096 0.227 0.032 DBMET02097 0.326 0.007 DBMET02098 0.378 0.004 DBMET02099 | DBMET02094 | |
| 0.288 | 0.031 | 0.288 | P-glycoprotein inhibitor | |||
| 0.274 | 0.027 | 0.659 | RET inhibitor | 0.659 0.004 DBMET02094 0.544 0.005 DBMET02095 0.109 0.088 DBMET02096 0.166 0.053 DBMET02097 0.402 0.01 DBMET02098 0.552 0.005 DBMET02099 | DBMET02094 | |
| 0.255 | 0.017 | 0.572 | Aurora-A kinase inhibitor | 0.572 0.004 DBMET02094 0.502 0.005 DBMET02095 0.121 0.054 DBMET02096 0.156 0.037 DBMET02097 0.413 0.006 DBMET02098 0.538 0.005 DBMET02099 | DBMET02094 | |
| 0.258 | 0.026 | 0.441 | Cyclin-dependent kinase inhibitor | 0.403 0.011 DBMET02094 0.353 0.015 DBMET02095 0.297 0.02 DBMET02098 0.441 0.009 DBMET02099 | DBMET02099 | |
| 0.25 | 0.025 | 0.342 | c-Src kinase inhibitor | 0.342 0.013 DBMET02094 0.31 0.016 DBMET02095 0.183 0.041 DBMET02098 0.336 0.013 DBMET02099 | DBMET02094 | |
| 0.228 | 0.005 | 0.228 | Polo-like kinase-1 inhibitor | 0.221 0.005 DBMET02094 0.207 0.006 DBMET02095 0.109 0.037 DBMET02098 0.174 0.01 DBMET02099 | ||
| 0.229 | 0.01 | 0.229 | Beta amyloid protein antagonist | 0.201 0.016 DBMET02094 0.203 0.016 DBMET02095 0.132 0.056 DBMET02096 0.202 0.016 DBMET02097 0.133 0.054 DBMET02098 0.172 0.027 DBMET02099 | ||
| 0.222 | 0.005 | 0.222 | Cyclin-dependent kinase 4 inhibitor | 0.208 0.006 DBMET02094 0.184 0.008 DBMET02095 0.088 0.031 DBMET02096 0.06 0.051 DBMET02097 0.139 0.014 DBMET02098 0.219 0.005 DBMET02099 | ||
| 0.241 | 0.028 | 0.303 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.303 0.019 DBMET02094 0.22 0.032 DBMET02095 0.116 0.07 DBMET02098 0.258 0.025 DBMET02099 | DBMET02094 | |
| 0.226 | 0.031 | 0.41 | Lck kinase inhibitor | 0.41 0.008 DBMET02094 0.322 0.014 DBMET02095 0.104 0.098 DBMET02097 0.217 0.034 DBMET02098 0.325 0.014 DBMET02099 | DBMET02094 | |
| 0.197 | 0.004 | 0.197 | Cyclin D3 inhibitor | 0.099 0.007 DBMET02094 0.087 0.009 DBMET02095 0.038 0.029 DBMET02096 0.039 0.027 DBMET02097 0.065 0.015 DBMET02098 0.112 0.006 DBMET02099 | ||
| 0.259 | 0.067 | 0.259 | Antiamyloidogenic | 0.15 0.148 DBMET02097 | ||
| 0.199 | 0.014 | 0.199 | DNA directed RNA polymerase inhibitor | 0.095 0.062 DBMET02094 0.101 0.055 DBMET02095 0.103 0.054 DBMET02098 0.109 0.047 DBMET02099 | ||
| 0.241 | 0.089 | 0.241 | Cardiotonic | |||
| 0.192 | 0.049 | 0.507 | Protein-tyrosine kinase Lyn inhibitor | 0.507 0.004 DBMET02094 0.428 0.005 DBMET02095 0.134 0.074 DBMET02096 0.176 0.055 DBMET02097 0.36 0.01 DBMET02098 0.434 0.005 DBMET02099 | DBMET02094 | |
| 0.214 | 0.081 | 0.214 | RNA-directed DNA polymerase inhibitor | |||
| 0.17 | 0.039 | 0.17 | DNA polymerase I inhibitor | |||
| 0.143 | 0.013 | 0.143 | Purinergic P2X2 antagonist | |||
| 0.132 | 0.006 | 0.23 | ZAP-70 protein tyrosine kinase inhibitor | 0.23 0.004 DBMET02094 0.174 0.004 DBMET02095 0.094 0.018 DBMET02096 0.1 0.014 DBMET02097 0.14 0.005 DBMET02098 0.178 0.004 DBMET02099 | DBMET02094 | |
| 0.216 | 0.096 | 0.246 | Tumour necrosis factor alpha release inhibitor | 0.246 0.077 DBMET02097 | DBMET02097 | |
| 0.259 | 0.141 | 0.339 | Immunosuppressant | 0.309 0.109 DBMET02096 0.339 0.092 DBMET02097 | DBMET02097 | |
| 0.209 | 0.09 | 0.352 | Angiogenesis stimulant | 0.3 0.049 DBMET02096 0.352 0.032 DBMET02097 0.181 0.105 DBMET02098 | DBMET02097 | |
| 0.131 | 0.025 | 0.159 | Aminoacyl-tRNA synthetase inhibitor | 0.13 0.026 DBMET02094 0.131 0.025 DBMET02095 0.08 0.077 DBMET02096 0.113 0.034 DBMET02097 0.111 0.036 DBMET02098 0.159 0.017 DBMET02099 | DBMET02099 | |
| 0.113 | 0.01 | 0.149 | Protein kinase C epsilon inhibitor | 0.148 0.006 DBMET02094 0.144 0.007 DBMET02095 0.059 0.032 DBMET02096 0.056 0.034 DBMET02097 0.087 0.017 DBMET02098 0.149 0.006 DBMET02099 | DBMET02099 | |
| 0.135 | 0.035 | 0.214 | CDK/cyclin complex inhibitor | 0.196 0.02 DBMET02094 0.169 0.025 DBMET02095 0.107 0.047 DBMET02098 0.214 0.017 DBMET02099 | DBMET02099 | |
| 0.099 | 0.019 | 0.193 | CDK9/cyclin T1 inhibitor | 0.184 0.007 DBMET02094 0.15 0.01 DBMET02095 0.058 0.042 DBMET02096 0.058 0.042 DBMET02097 0.108 0.017 DBMET02098 0.193 0.007 DBMET02099 | DBMET02099 | |
| 0.147 | 0.073 | 0.394 | MAP kinase 3 inhibitor | 0.384 0.003 DBMET02094 0.394 0.003 DBMET02095 0.156 0.059 DBMET02097 0.237 0.011 DBMET02098 0.361 0.004 DBMET02099 | DBMET02095 | |
| 0.096 | 0.033 | 0.177 | Focal adhesion kinase 1 inhibitor | 0.177 0.005 DBMET02094 0.154 0.009 DBMET02095 0.085 0.044 DBMET02096 0.094 0.035 DBMET02097 0.134 0.013 DBMET02098 0.147 0.01 DBMET02099 | DBMET02094 | |
| 0.084 | 0.022 | 0.089 | CDK4/cyclin D1 inhibitor | 0.085 0.021 DBMET02094 0.078 0.026 DBMET02095 0.056 0.043 DBMET02098 0.089 0.019 DBMET02099 | DBMET02099 | |
| 0.082 | 0.021 | 0.103 | CDK4/cyclin D inhibitor | 0.099 0.015 DBMET02094 0.087 0.019 DBMET02095 0.066 0.03 DBMET02098 0.103 0.014 DBMET02099 | DBMET02099 | |
| 0.164 | 0.103 | 0.535 | Death-associated protein kinase 3 inhibitor | 0.53 0.005 DBMET02094 0.499 0.006 DBMET02095 0.16 0.108 DBMET02096 0.283 0.042 DBMET02097 0.436 0.012 DBMET02098 0.535 0.005 DBMET02099 | DBMET02099 | |
| 0.058 | 0.005 | 0.058 | CDK6/cyclin D3 inhibitor | 0.051 0.006 DBMET02094 0.046 0.009 DBMET02095 0.031 0.029 DBMET02097 0.04 0.014 DBMET02098 0.051 0.006 DBMET02099 | ||
| 0.123 | 0.07 | 0.253 | Epidermal growth factor receptor kinase inhibitor | 0.253 0.015 DBMET02094 0.226 0.019 DBMET02095 0.111 0.083 DBMET02097 0.179 0.033 DBMET02098 0.215 0.022 DBMET02099 | DBMET02094 | |
| 0.106 | 0.057 | 0.239 | Cyclin-dependent kinase 9 inhibitor | 0.23 0.017 DBMET02094 0.198 0.023 DBMET02095 0.097 0.066 DBMET02098 0.239 0.015 DBMET02099 | DBMET02099 | |
| 0.072 | 0.025 | 0.072 | Potassium channel (Ca-activated) blocker | |||
| 0.085 | 0.038 | 0.085 | Nav1.8 sodium channel blocker | |||
| 0.08 | 0.042 | 0.08 | HIV-1 reverse transcriptase inhibitor | |||
| 0.048 | 0.011 | 0.048 | Purinergic P2Y2 antagonist | |||
| 0.081 | 0.048 | 0.081 | Viral attachment inhibitor | |||
| 0.036 | 0.006 | 0.036 | Toll-Like receptor 4 agonist | 0.029 0.013 DBMET02096 0.03 0.012 DBMET02097 0.026 0.019 DBMET02098 | ||
| 0.062 | 0.034 | 0.091 | Protein kinase C theta inhibitor | 0.091 0.01 DBMET02094 0.084 0.012 DBMET02095 0.07 0.023 DBMET02098 0.087 0.011 DBMET02099 | DBMET02094 | |
| 0.038 | 0.013 | 0.038 | Purinergic P2X agonist | |||
| 0.061 | 0.037 | 0.386 | Tyrosine-protein kinase EMT inhibitor | 0.386 0.004 DBMET02094 0.278 0.005 DBMET02095 0.071 0.03 DBMET02097 0.187 0.005 DBMET02098 0.323 0.004 DBMET02099 | DBMET02094 | |
| 0.101 | 0.078 | 0.387 | Glycogen synthase kinase-3 inhibitor | 0.387 0.009 DBMET02094 0.314 0.014 DBMET02095 0.185 0.035 DBMET02098 0.367 0.01 DBMET02099 | DBMET02094 | |
| 0.058 | 0.037 | 0.266 | Bruton tyrosine kinase inhibitor | 0.264 0.005 DBMET02094 0.202 0.005 DBMET02095 0.142 0.008 DBMET02098 0.266 0.005 DBMET02099 | DBMET02099 | |
| 0.079 | 0.06 | 0.278 | ALK inhibitor | 0.278 0.006 DBMET02094 0.237 0.008 DBMET02095 0.08 0.06 DBMET02097 0.174 0.015 DBMET02098 0.249 0.008 DBMET02099 | DBMET02094 | |
| 0.104 | 0.091 | 0.104 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.093 | 0.08 | 0.093 | Folate antagonist | |||
| 0.067 | 0.055 | 0.237 | Janus tyrosine kinase 3 inhibitor | 0.237 0.008 DBMET02094 0.188 0.013 DBMET02095 0.129 0.024 DBMET02098 0.231 0.008 DBMET02099 | DBMET02094 | |
| 0.086 | 0.076 | 0.347 | Protein kinase (CK2) inhibitor | 0.256 0.01 DBMET02094 0.309 0.006 DBMET02095 0.082 0.081 DBMET02098 0.347 0.004 DBMET02099 | DBMET02099 | |
| 0.087 | 0.077 | 0.385 | Cyclin-dependent kinase 1 inhibitor | 0.347 0.008 DBMET02094 0.335 0.009 DBMET02095 0.142 0.044 DBMET02096 0.104 0.063 DBMET02097 0.226 0.022 DBMET02098 0.385 0.006 DBMET02099 | DBMET02099 | |
| 0.008 | 0.006 | 0.008 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.12 | 0.127 | 0.59 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.581 0.005 DBMET02094 0.518 0.005 DBMET02095 0.246 0.049 DBMET02097 0.397 0.011 DBMET02098 0.59 0.005 DBMET02099 | DBMET02099 | |
| 0.06 | 0.07 | 0.243 | ErbB-4 antagonist | 0.243 0.008 DBMET02094 0.199 0.013 DBMET02095 0.069 0.061 DBMET02097 0.161 0.018 DBMET02098 0.21 0.011 DBMET02099 | DBMET02094 | |
| 0.048 | 0.059 | 0.088 | Cyclin H inhibitor | 0.08 0.019 DBMET02094 0.076 0.022 DBMET02095 0.066 0.032 DBMET02098 0.088 0.013 DBMET02099 | DBMET02099 | |
| 0.125 | 0.137 | 0.135 | Interleukin 6 antagonist | 0.135 0.115 DBMET02097 | DBMET02097 | |
| 0.076 | 0.092 | 0.262 | Ephrin antagonist | 0.262 0.013 DBMET02094 0.211 0.021 DBMET02095 0.087 0.076 DBMET02097 0.142 0.039 DBMET02098 0.199 0.024 DBMET02099 | DBMET02094 | |
| 0.066 | 0.085 | 0.133 | ErbB-3 antagonist | 0.133 0.024 DBMET02094 0.114 0.032 DBMET02095 0.099 0.041 DBMET02098 0.103 0.039 DBMET02099 | DBMET02094 | |
| 0.054 | 0.076 | 0.237 | Janus tyrosine kinase 2 inhibitor | 0.237 0.008 DBMET02094 0.176 0.015 DBMET02095 0.124 0.027 DBMET02098 0.214 0.01 DBMET02099 | DBMET02094 | |
| 0.089 | 0.114 | 0.102 | Tubulin antagonist | 0.102 0.099 DBMET02094 | DBMET02094 | |
| 0.035 | 0.062 | 0.055 | CDK7/cyclin H inhibitor | 0.054 0.021 DBMET02094 0.049 0.025 DBMET02095 0.043 0.035 DBMET02098 0.055 0.019 DBMET02099 | DBMET02099 | |
| 0.094 | 0.123 | 0.362 | Growth factor antagonist | 0.362 0.021 DBMET02094 0.285 0.029 DBMET02095 0.191 0.049 DBMET02098 0.281 0.03 DBMET02099 | DBMET02094 | |
| 0.079 | 0.112 | 0.467 | Aurora-B kinase inhibitor | 0.467 0.005 DBMET02094 0.39 0.008 DBMET02095 0.18 0.036 DBMET02098 0.366 0.01 DBMET02099 | DBMET02094 | |
| 0.119 | 0.162 | 0.589 | I kappa B kinase epsilon inhibitor | 0.589 0.002 DBMET02094 0.499 0.003 DBMET02095 0.234 0.046 DBMET02097 0.349 0.005 DBMET02098 0.486 0.003 DBMET02099 | DBMET02094 | |
| 0.079 | 0.125 | 0.292 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.208 0.039 DBMET02094 0.242 0.031 DBMET02095 0.11 0.091 DBMET02098 0.292 0.019 DBMET02099 | DBMET02099 | |
| 0.099 | 0.146 | 0.522 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.52 0.005 DBMET02094 0.484 0.007 DBMET02095 0.251 0.045 DBMET02097 0.429 0.013 DBMET02098 0.522 0.005 DBMET02099 | DBMET02099 | |
| 0.105 | 0.154 | 0.519 | TRKC antagonist | 0.519 0.005 DBMET02094 0.466 0.008 DBMET02095 0.205 0.065 DBMET02097 0.348 0.016 DBMET02098 0.518 0.005 DBMET02099 | DBMET02094 | |
| 0.062 | 0.111 | 0.164 | CDK2/cyclin A inhibitor | 0.146 0.027 DBMET02094 0.133 0.034 DBMET02095 0.101 0.057 DBMET02098 0.164 0.022 DBMET02099 | DBMET02099 | |
| 0.069 | 0.122 | 0.305 | Glycogen synthase kinase-3 beta inhibitor | 0.305 0.013 DBMET02094 0.251 0.02 DBMET02095 0.142 0.047 DBMET02098 0.285 0.015 DBMET02099 | DBMET02094 | |
| 0.036 | 0.09 | 0.15 | Cyclin-dependent kinase 6 inhibitor | 0.114 0.007 DBMET02094 0.098 0.011 DBMET02095 0.063 0.037 DBMET02098 0.15 0.004 DBMET02099 | DBMET02099 | |
| 0.034 | 0.09 | 0.095 | CDK1/cyclin B inhibitor | 0.088 0.03 DBMET02094 0.082 0.033 DBMET02095 0.095 0.027 DBMET02099 | DBMET02099 | |
| 0.026 | 0.087 | 0.103 | CDK2/cyclin E inhibitor | 0.103 0.022 DBMET02094 0.084 0.029 DBMET02095 0.058 0.044 DBMET02098 0.103 0.022 DBMET02099 | DBMET02099 | |
| 0.042 | 0.111 | 0.167 | CDK2/cyclin E2 inhibitor | 0.137 0.019 DBMET02094 0.117 0.023 DBMET02095 0.071 0.047 DBMET02098 0.167 0.014 DBMET02099 | DBMET02099 | |
| 0.058 | 0.128 | 0.305 | MAP kinase 9 inhibitor | 0.305 0.011 DBMET02094 0.214 0.02 DBMET02095 0.151 0.037 DBMET02098 0.288 0.013 DBMET02099 | DBMET02094 | |
| 0.048 | 0.118 | 0.176 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.176 0.008 DBMET02094 0.16 0.011 DBMET02095 0.132 0.02 DBMET02098 0.166 0.01 DBMET02099 | DBMET02094 | |
| 0.048 | 0.118 | 0.24 | Platelet activating factor beta antagonist | 0.24 0.018 DBMET02094 0.155 0.036 DBMET02095 0.106 0.059 DBMET02098 0.12 0.05 DBMET02099 | DBMET02094 | |
| 0.038 | 0.113 | 0.134 | CDK1/cyclin B1 inhibitor | 0.116 0.023 DBMET02094 0.125 0.021 DBMET02095 0.133 0.019 DBMET02096 0.066 0.052 DBMET02098 0.134 0.019 DBMET02099 | DBMET02099 | |
| 0.082 | 0.16 | 0.446 | Protein kinase C nu inhibitor | 0.446 0.006 DBMET02094 0.444 0.007 DBMET02095 0.193 0.05 DBMET02097 0.314 0.022 DBMET02098 0.444 0.006 DBMET02099 | DBMET02094 | |
| 0.059 | 0.139 | 0.249 | Vascular endothelial growth factor antagonist | 0.249 0.029 DBMET02094 0.17 0.047 DBMET02095 0.105 0.078 DBMET02098 0.174 0.046 DBMET02099 | DBMET02094 | |
| 0.055 | 0.146 | 0.166 | Platelet activating factor antagonist | 0.166 0.037 DBMET02094 0.094 0.084 DBMET02095 | DBMET02094 | |
| 0.068 | 0.162 | 0.163 | Cyclin-dependent kinase 7 inhibitor | 0.16 0.053 DBMET02094 0.135 0.071 DBMET02095 0.163 0.051 DBMET02099 | DBMET02099 | |
| 0.019 | 0.116 | 0.202 | Tyk2 inhibitor | 0.202 0.008 DBMET02094 0.146 0.014 DBMET02095 0.105 0.026 DBMET02098 0.187 0.009 DBMET02099 | DBMET02094 | |
| 0.045 | 0.146 | 0.225 | Vascular endothelial growth factor 2 antagonist | 0.225 0.03 DBMET02094 0.15 0.049 DBMET02095 0.153 0.048 DBMET02099 | DBMET02094 | |
| 0.087 | 0.189 | 0.426 | Clk dual-specificity kinase inhibitor | 0.426 0.015 DBMET02094 0.389 0.021 DBMET02095 0.137 0.127 DBMET02097 0.262 0.05 DBMET02098 0.418 0.016 DBMET02099 | DBMET02094 | |
| 0.063 | 0.167 | 0.165 | Vascular endothelial growth factor 3 antagonist | 0.165 0.057 DBMET02094 0.123 0.092 DBMET02095 | DBMET02094 | |
| 0.024 | 0.13 | 0.058 | Fibroblast growth factor 4 antagonist | 0.056 0.042 DBMET02094 0.058 0.041 DBMET02099 | DBMET02099 | |
| 0.104 | 0.216 | 0.335 | Focal adhesion kinase 2 inhibitor | 0.335 0.008 DBMET02094 0.286 0.021 DBMET02095 0.214 0.059 DBMET02098 0.267 0.029 DBMET02099 | DBMET02094 | |
| 0.038 | 0.163 | 0.212 | Fibroblast growth factor 1 antagonist | 0.212 0.014 DBMET02094 0.172 0.024 DBMET02095 0.177 0.023 DBMET02098 0.189 0.019 DBMET02099 | DBMET02094 | |
| 0.029 | 0.154 | 0.068 | Protein kinase C iota inhibitor | 0.068 0.034 DBMET02094 0.063 0.038 DBMET02095 0.057 0.044 DBMET02099 | DBMET02094 | |
| 0.044 | 0.171 | 0.227 | Vascular endothelial growth factor 1 antagonist | 0.227 0.021 DBMET02094 0.155 0.039 DBMET02095 0.147 0.042 DBMET02099 | DBMET02094 | |
| 0.049 | 0.177 | 0.232 | Cyclin-dependent kinase 2 inhibitor | 0.224 0.02 DBMET02094 0.182 0.028 DBMET02095 0.124 0.05 DBMET02098 0.232 0.019 DBMET02099 | DBMET02099 | |
| 0.096 | 0.225 | 0.168 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.165 0.049 DBMET02094 0.159 0.057 DBMET02095 0.132 0.111 DBMET02098 0.168 0.045 DBMET02099 | DBMET02099 | |
| 0.058 | 0.19 | 0.326 | TRKB antagonist | 0.326 0.008 DBMET02094 0.262 0.015 DBMET02095 0.186 0.029 DBMET02098 0.27 0.014 DBMET02099 | DBMET02094 | |
| 0.04 | 0.18 | 0.156 | AXL receptor tyrosine kinase inhibitor | 0.156 0.016 DBMET02094 0.137 0.021 DBMET02095 0.091 0.048 DBMET02098 0.119 0.028 DBMET02099 | DBMET02094 | |
| 0.067 | 0.213 | 0.429 | CDC-like kinase 4 inhibitor | 0.429 0.012 DBMET02094 0.359 0.019 DBMET02095 0.157 0.096 DBMET02097 0.273 0.039 DBMET02098 0.405 0.014 DBMET02099 | DBMET02094 | |
| 0.133 | 0.279 | 0.336 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.336 0.042 DBMET02094 0.314 0.055 DBMET02095 0.252 0.105 DBMET02098 0.329 0.046 DBMET02099 | DBMET02094 | |
| 0.037 | 0.185 | 0.163 | Platelet activating factor alpha antagonist | 0.163 0.026 DBMET02094 0.123 0.042 DBMET02095 0.093 0.065 DBMET02099 | DBMET02094 | |
| 0.052 | 0.203 | 0.291 | MAP kinase 12 inhibitor | 0.291 0.007 DBMET02094 0.254 0.011 DBMET02095 0.111 0.082 DBMET02097 0.213 0.019 DBMET02098 0.291 0.007 DBMET02099 | DBMET02099 | |
| 0.037 | 0.196 | 0.45 | Protein kinase (CK2) alpha inhibitor | 0.372 0.006 DBMET02094 0.419 0.004 DBMET02095 0.13 0.055 DBMET02098 0.45 0.004 DBMET02099 | DBMET02099 | |
| 0.035 | 0.196 | 0.092 | Epidermal growth factor antagonist | 0.092 0.051 DBMET02094 0.087 0.057 DBMET02095 0.078 0.069 DBMET02099 | DBMET02094 | |
| 0.028 | 0.19 | 0.068 | DNA gyrase inhibitor | 0.068 0.038 DBMET02097 0.056 0.055 DBMET02099 | DBMET02097 | |
| 0.045 | 0.208 | 0.189 | EphA2 antagonist | 0.189 0.016 DBMET02094 0.164 0.024 DBMET02095 0.125 0.05 DBMET02097 0.138 0.038 DBMET02098 0.14 0.037 DBMET02099 | DBMET02094 | |
| 0.041 | 0.208 | 0.217 | MAP kinase 8 inhibitor | 0.217 0.014 DBMET02094 0.169 0.023 DBMET02095 0.121 0.042 DBMET02098 0.199 0.017 DBMET02099 | DBMET02094 | |
| 0.022 | 0.19 | 0.044 | Guanylate cyclase stimulant | 0.04 0.039 DBMET02094 0.044 0.03 DBMET02099 | DBMET02099 | |
| 0.085 | 0.256 | 0.478 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.459 0.011 DBMET02094 0.407 0.016 DBMET02095 0.178 0.09 DBMET02097 0.322 0.037 DBMET02098 0.478 0.01 DBMET02099 | DBMET02099 | |
| 0.026 | 0.204 | 0.292 | Leucine-rich repeat kinase 2 inhibitor | 0.292 0.004 DBMET02094 0.202 0.01 DBMET02095 0.136 0.025 DBMET02098 0.19 0.011 DBMET02099 | DBMET02094 | |
| 0.01 | 0.195 | 0.079 | Cyclin E1 inhibitor | 0.069 0.029 DBMET02094 0.054 0.035 DBMET02095 0.079 0.025 DBMET02099 | DBMET02099 | |
| 0.129 | 0.318 | 0.501 | Toll-Like receptor agonist | 0.501 0.032 DBMET02094 0.483 0.035 DBMET02095 0.407 0.057 DBMET02097 0.33 0.093 DBMET02098 0.496 0.033 DBMET02099 | DBMET02094 | |
| 0.051 | 0.251 | 0.074 | MAP kinase 7 inhibitor | 0.074 0.072 DBMET02094 | DBMET02094 | |
| 0.026 | 0.231 | 0.268 | Insulin like growth factor 1 antagonist | 0.268 0.005 DBMET02094 0.229 0.007 DBMET02095 0.093 0.047 DBMET02098 0.166 0.016 DBMET02099 | DBMET02094 | |
| 0.053 | 0.258 | 0.225 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.21 0.038 DBMET02094 0.193 0.046 DBMET02095 0.124 0.102 DBMET02098 0.225 0.032 DBMET02099 | DBMET02099 | |
| 0.025 | 0.238 | 0.274 | Insulin growth factor antagonist | 0.274 0.005 DBMET02094 0.242 0.006 DBMET02095 0.097 0.048 DBMET02098 0.179 0.015 DBMET02099 | DBMET02094 | |
| 0.009 | 0.224 | 0.086 | Cyclin E inhibitor | 0.075 0.034 DBMET02094 0.059 0.042 DBMET02095 0.086 0.03 DBMET02099 | DBMET02099 | |
| 0.032 | 0.25 | 0.181 | Polo-like kinase-4 inhibitor | 0.181 0.021 DBMET02094 0.159 0.03 DBMET02095 0.118 0.058 DBMET02098 0.167 0.026 DBMET02099 | DBMET02094 | |
| 0.026 | 0.244 | 0.086 | ErbB-2 antagonist | 0.086 0.043 DBMET02094 0.066 0.065 DBMET02095 | DBMET02094 | |
| 0.091 | 0.323 | 0.178 | Death-associated protein kinase 2 inhibitor | 0.155 0.094 DBMET02094 0.163 0.079 DBMET02095 0.178 0.056 DBMET02099 | DBMET02099 | |
| 0.041 | 0.275 | 0.243 | MAP kinase 13 inhibitor | 0.237 0.013 DBMET02094 0.207 0.019 DBMET02095 0.157 0.033 DBMET02098 0.243 0.011 DBMET02099 | DBMET02099 | |
| 0.042 | 0.279 | 0.119 | Protein kinase (CK1) gamma 2 inhibitor | 0.119 0.066 DBMET02094 0.101 0.082 DBMET02095 0.116 0.068 DBMET02099 | DBMET02094 | |
| 0.039 | 0.287 | 0.214 | CDC-like kinase 2 inhibitor | 0.214 0.059 DBMET02094 0.174 0.08 DBMET02095 0.205 0.064 DBMET02099 | DBMET02094 | |
| 0.018 | 0.268 | 0.202 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.198 0.01 DBMET02094 0.175 0.014 DBMET02095 0.092 0.055 DBMET02098 0.202 0.009 DBMET02099 | DBMET02099 | |
| 0.054 | 0.311 | 0.176 | Protein kinase (CK1) gamma 3 inhibitor | 0.161 0.078 DBMET02094 0.151 0.088 DBMET02095 0.176 0.064 DBMET02099 | DBMET02099 | |
| 0.094 | 0.353 | 0.168 | Cyclin-dependent kinase 3 inhibitor | 0.15 0.095 DBMET02094 0.151 0.094 DBMET02095 0.168 0.063 DBMET02099 | DBMET02099 | |
| 0.022 | 0.287 | 0.213 | Cyclin-dependent kinase 5 inhibitor | 0.182 0.027 DBMET02094 0.167 0.032 DBMET02095 0.104 0.072 DBMET02098 0.213 0.02 DBMET02099 | DBMET02099 | |
| 0.016 | 0.282 | 0.113 | Bromodomain-containing protein 4 inhibitor | 0.113 0.011 DBMET02094 0.084 0.017 DBMET02095 0.063 0.03 DBMET02098 0.102 0.013 DBMET02099 | DBMET02094 | |
| 0.033 | 0.302 | 0.276 | Insulin receptor antagonist | 0.276 0.005 DBMET02094 0.247 0.007 DBMET02095 0.132 0.035 DBMET02098 0.224 0.011 DBMET02099 | DBMET02094 | |
| 0.013 | 0.297 | 0.068 | Cyclin B1 inhibitor | 0.068 0.034 DBMET02099 | DBMET02099 | |
| 0.042 | 0.328 | 0.081 | Transcription factor NF kappa B stimulant | 0.081 0.068 DBMET02097 | DBMET02097 | |
| 0.098 | 0.394 | 0.478 | Toll-Like receptor 7 agonist | 0.478 0.036 DBMET02094 0.464 0.039 DBMET02095 0.379 0.068 DBMET02097 0.294 0.114 DBMET02098 0.477 0.037 DBMET02099 | DBMET02094 | |
| 0.031 | 0.33 | 0.133 | Protein kinase (CK1) gamma inhibitor | 0.133 0.078 DBMET02094 0.113 0.098 DBMET02095 0.133 0.078 DBMET02099 | DBMET02099 | |
| 0.01 | 0.322 | 0.054 | Cyclin B inhibitor | 0.054 0.039 DBMET02099 | DBMET02099 | |
| 0.018 | 0.332 | 0.074 | Cyclin B3 inhibitor | 0.074 0.042 DBMET02099 | DBMET02099 | |
| 0.053 | 0.37 | 0.16 | Platelet aggregation inhibitor | 0.16 0.117 DBMET02094 | DBMET02094 | |
| 0.014 | 0.331 | 0.101 | MAP kinase 10 inhibitor | 0.101 0.034 DBMET02094 0.076 0.056 DBMET02095 0.071 0.063 DBMET02098 0.089 0.042 DBMET02099 | DBMET02094 | |
| 0.038 | 0.369 | 0.232 | Activin receptor-like kinase 2 inhibitor | 0.232 0.025 DBMET02094 0.163 0.057 DBMET02095 0.154 0.064 DBMET02099 | DBMET02094 | |
| 0.033 | 0.369 | 0.123 | Protein kinase (CK1) gamma 1 inhibitor | 0.117 0.101 DBMET02094 0.123 0.095 DBMET02099 | DBMET02099 | |
| 0.042 | 0.378 | 0.146 | MAP3K9 inhibitor | 0.136 0.084 DBMET02094 0.137 0.082 DBMET02095 0.146 0.067 DBMET02099 | DBMET02099 | |
| 0.1 | 0.44 | 0.16 | ErbB-1 antagonist | 0.16 0.155 DBMET02095 | DBMET02095 | |
| 0.009 | 0.361 | 0.053 | Cyclin B2 inhibitor | 0.053 0.042 DBMET02099 | DBMET02099 | |
| 0.018 | 0.373 | 0.08 | Phosphodiesterase 3A inhibitor | 0.08 0.056 DBMET02094 | DBMET02094 | |
| 0.023 | 0.382 | 0.128 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.116 0.087 DBMET02094 0.128 0.078 DBMET02099 | DBMET02099 | |
| 0.086 | 0.45 | 0.14 | CC chemokine 6 receptor antagonist | 0.12 0.116 DBMET02095 0.136 0.051 DBMET02096 0.14 0.041 DBMET02097 0.12 0.117 DBMET02099 | DBMET02097 | |
| 0.018 | 0.385 | 0.718 | Glycogen synthase kinase-3 alpha inhibitor | 0.591 0.004 DBMET02094 0.587 0.004 DBMET02095 0.23 0.032 DBMET02098 0.718 0.003 DBMET02099 | DBMET02099 | |
| 0.026 | 0.405 | 0.17 | Phosphodiesterase inhibitor | 0.17 0.046 DBMET02094 0.127 0.075 DBMET02095 | DBMET02094 | |
| 0.008 | 0.401 | 0.182 | Fibroblast growth factor 3 antagonist | 0.182 0.009 DBMET02094 0.133 0.019 DBMET02095 0.073 0.06 DBMET02098 0.146 0.015 DBMET02099 | DBMET02094 | |
| 0.022 | 0.431 | 0.387 | Dyrk kinase inhibitor | 0.348 0.038 DBMET02094 0.344 0.038 DBMET02095 0.145 0.141 DBMET02097 0.163 0.124 DBMET02098 0.387 0.029 DBMET02099 | DBMET02099 | |
| 0.013 | 0.426 | 0.047 | Antibiotic Aminoglycoside-like | 0.04 0.021 DBMET02096 0.047 0.015 DBMET02097 | DBMET02097 | |
| 0.024 | 0.446 | 0.158 | Lipid peroxidase inhibitor | 0.135 0.079 DBMET02096 0.158 0.063 DBMET02097 | DBMET02097 | |
| 0.01 | 0.473 | 0.06 | Protein 50S ribosomal subunit inhibitor | 0.06 0.031 DBMET02097 | DBMET02097 | |
| 0.008 | 0.476 | 0.065 | Check point kinase 1 inhibitor | 0.065 0.05 DBMET02099 | DBMET02099 | |
| 0.021 | 0.489 | 0.195 | Thrombolytic | 0.153 0.08 DBMET02096 0.195 0.054 DBMET02097 | DBMET02097 | |
| 0.013 | 0.528 | 0.412 | Tyrosine-protein kinase receptor antagonist | 0.412 0.008 DBMET02094 0.334 0.014 DBMET02095 0.146 0.067 DBMET02098 0.32 0.015 DBMET02099 | DBMET02094 | |
| 0.01 | 0.526 | 0.213 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.174 0.11 DBMET02094 0.187 0.101 DBMET02095 0.213 0.085 DBMET02099 | DBMET02099 | |
| 0.009 | 0.531 | 0.095 | Protein kinase A inhibitor | 0.075 0.065 DBMET02094 0.095 0.049 DBMET02095 0.089 0.053 DBMET02099 | DBMET02095 | |
| 0.008 | 0.547 | 0.07 | Phosphodiesterase 5A inhibitor | 0.07 0.05 DBMET02094 | DBMET02094 | |
| 0.052 | 0.598 | 0.188 | MAP-kinase-activated kinase 5 inhibitor | 0.166 0.155 DBMET02095 0.188 0.12 DBMET02099 | DBMET02099 | |
| 0.006 | 0.553 | 0.068 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.068 0.063 DBMET02099 | DBMET02099 | |
| 0.008 | 0.56 | 0.069 | Phosphodiesterase V inhibitor | 0.069 0.053 DBMET02094 | DBMET02094 | |
| 0.012 | 0.58 | 0.219 | Protein kinase C gamma inhibitor | 0.202 0.014 DBMET02094 0.219 0.011 DBMET02095 0.216 0.011 DBMET02099 | DBMET02095 | |
| 0.014 | 0.583 | 0.326 | MAP kinase kinase 2 inhibitor | 0.297 0.036 DBMET02094 0.256 0.051 DBMET02095 0.326 0.027 DBMET02099 | DBMET02099 | |
| 0.011 | 0.58 | 0.5 | Topoisomerase I inhibitor | 0.5 0.004 DBMET02096 0.095 0.074 DBMET02097 | DBMET02096 | |
| 0.051 | 0.635 | 0.628 | Cyclophilin D inhibitor | 0.289 0.173 DBMET02096 0.628 0.023 DBMET02097 0.283 0.178 DBMET02098 0.284 0.177 DBMET02099 | DBMET02097 | |
| 0.007 | 0.595 | 0.167 | CDC7 inhibitor | 0.137 0.012 DBMET02094 0.106 0.02 DBMET02095 0.167 0.008 DBMET02099 | DBMET02099 | |
| 0.006 | 0.601 | 0.219 | MAP kinase kinase kinase inhibitor | 0.2 0.018 DBMET02094 0.158 0.031 DBMET02095 0.219 0.014 DBMET02099 | DBMET02099 | |
| 0.009 | 0.607 | 0.119 | Topoisomerase II inhibitor | 0.119 0.068 DBMET02097 | DBMET02097 | |
| 0.012 | 0.613 | 0.132 | Ribosomal protein S6 kinase inhibitor | 0.123 0.087 DBMET02094 0.109 0.104 DBMET02095 0.132 0.079 DBMET02099 | DBMET02099 | |
| 0.004 | 0.623 | 0.071 | Cyclin A2 inhibitor | 0.071 0.038 DBMET02099 | DBMET02099 | |
| 0.007 | 0.626 | 0.148 | TRKA antagonist | 0.148 0.051 DBMET02094 0.114 0.072 DBMET02095 0.11 0.077 DBMET02099 | DBMET02094 | |
| 0.013 | 0.646 | 0.359 | Potassium channel blocker | 0.359 0.03 DBMET02094 0.26 0.062 DBMET02095 0.304 0.045 DBMET02099 | DBMET02094 | |
| 0.017 | 0.656 | 0.324 | Antioxidant | 0.23 0.095 DBMET02096 0.324 0.054 DBMET02097 | DBMET02097 | |
| 0.004 | 0.658 | 0.056 | Cyclin A inhibitor | 0.056 0.048 DBMET02099 | DBMET02099 | |
| 0.03 | 0.688 | 0.259 | Hepatoprotectant | 0.196 0.067 DBMET02096 0.259 0.041 DBMET02097 | DBMET02097 | |
| 0.014 | 0.715 | 0.219 | Nitric oxide antagonist | 0.159 0.088 DBMET02096 0.219 0.061 DBMET02097 | DBMET02097 | |
| 0.014 | 0.72 | 0.278 | Hemostatic | 0.142 0.079 DBMET02096 0.278 0.018 DBMET02097 0.143 0.076 DBMET02098 | DBMET02097 | |
| 0.005 | 0.73 | 0.212 | LIM domain kinase 1 inhibitor | 0.212 0.058 DBMET02094 0.161 0.087 DBMET02095 0.2 0.063 DBMET02099 | DBMET02094 | |
| 0.003 | 0.777 | 0.1 | Pim-3 kinase inhibitor | 0.088 0.061 DBMET02094 0.1 0.045 DBMET02099 | DBMET02099 | |
| 0.018 | 0.809 | 0.282 | MAP kinase 1 inhibitor | 0.282 0.201 DBMET02094 0.245 0.239 DBMET02095 | DBMET02094 | |
| 0.018 | 0.81 | 0.134 | CF transmembrane conductance regulator agonist | 0.134 0.108 DBMET02099 | DBMET02099 | |
| 0.004 | 0.818 | 0.103 | I kappa B kinase inhibitor | 0.103 0.036 DBMET02099 | DBMET02099 | |
| 0.008 | 0.826 | 0.412 | Antibacterial | 0.412 0.071 DBMET02097 | DBMET02097 | |
| 0.026 | 0.86 | 0.207 | Caspase 3 stimulant | 0.207 0.159 DBMET02097 | DBMET02097 | |
| 0.005 | 0.842 | 0.131 | Bronchodilator | 0.118 0.046 DBMET02094 0.131 0.039 DBMET02095 0.103 0.06 DBMET02099 | DBMET02095 | |
| 0.014 | 0.852 | 0.236 | Vasodilator, coronary | 0.236 0.148 DBMET02097 | DBMET02097 | |
| 0.007 | 0.848 | 0.038 | Cholecystokinin B agonist | 0.038 0.025 DBMET02098 | DBMET02098 | |
| 0.004 | 0.849 | 0.247 | HERG channel blocker | 0.247 0.067 DBMET02094 0.168 0.112 DBMET02095 0.208 0.086 DBMET02099 | DBMET02094 | |
| 0.005 | 0.86 | 0.244 | Potassium channel (Voltage-sensitive) blocker | 0.244 0.07 DBMET02094 0.174 0.117 DBMET02095 0.205 0.093 DBMET02099 | DBMET02094 | |
| 0.005 | 0.88 | 0.297 | Free radical scavenger | 0.187 0.109 DBMET02096 0.297 0.053 DBMET02097 | DBMET02097 | |
| 0.019 | 0.895 | 0.247 | Apoptosis antagonist | 0.247 0.131 DBMET02097 | DBMET02097 | |
| 0.02 | 0.94 | 0.128 | NOS3 expression enhancer | 0.128 0.1 DBMET02097 | DBMET02097 | |
| 0.037 | 0.978 | 0.267 | Peptidyltransferase inhibitor | 0.237 0.061 DBMET02096 0.267 0.04 DBMET02097 | DBMET02097 | |
| 0.004 | 0.949 | 0.178 | Anticoagulant | 0.178 0.062 DBMET02098 | DBMET02098 | |
| 0.003 | 0.952 | 0.15 | Selectin antagonist | 0.091 0.031 DBMET02096 0.15 0.018 DBMET02097 | DBMET02097 | |
| 0.023 | 0.985 | 0.248 | Interleukin 2 agonist | 0.238 0.133 DBMET02096 0.248 0.12 DBMET02097 | DBMET02097 | |
| 0.005 | 0.976 | 0.229 | Hypoglycemic | 0.229 0.09 DBMET02097 | DBMET02097 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |